1
|
Laudadio G, Neigenfind P, Péter Á, Rubel CZ, Emmanuel MA, Oderinde MS, Ewing TEH, Palkowitz MD, Sloane JL, Gillman KW, Ridge D, Mandler MD, Bolduc PN, Nicastri MC, Zhang B, Clementson S, Petersen NN, Martín-Gago P, Mykhailiuk P, Engle KM, Baran PS. Nickel-Electrocatalytic Decarboxylative Arylation to Access Quaternary Centers. Angew Chem Int Ed Engl 2024; 63:e202314617. [PMID: 38181042 DOI: 10.1002/anie.202314617] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Revised: 01/04/2024] [Accepted: 01/05/2024] [Indexed: 01/07/2024]
Abstract
There is a pressing need, particularly in the field of drug discovery, for general methods that will enable direct coupling of tertiary alkyl fragments to (hetero)aryl halides. Herein a uniquely powerful and simple set of conditions for achieving this transformation with unparalleled generality and chemoselectivity is disclosed. This new protocol is placed in context with other recently reported methods, applied to simplify the routes of known bioactive building blocks molecules, and scaled up in both batch and flow. The role of pyridine additive as well as the mechanism of this reaction are interrogated through Cyclic Voltammetry studies, titration experiments, control reactions with Ni(0) and Ni(II)-complexes, and ligand optimization data. Those studies indicate that the formation of a BINAPNi(0) is minimized and the formation of an active pyridine-stabilized Ni(I) species is sustained during the reaction. Our preliminary mechanistic studies ruled out the involvement of Ni(0) species in this electrochemical cross-coupling, which is mediated by Ni(I) species via a Ni(I)-Ni(II)-Ni(III)-Ni(I) catalytic cycle.
Collapse
Affiliation(s)
- Gabriele Laudadio
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Philipp Neigenfind
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Áron Péter
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Camille Z Rubel
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Megan A Emmanuel
- Chemical Process Development, Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, NJ 08901, USA
| | - Martins S Oderinde
- Small Molecule Drug Discovery, Bristol Myers Squibb Research & Early Development, Route 206 & Province Line Road, Princeton, NJ 08543, USA
| | - Tamara El-Hayek Ewing
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Maximilian D Palkowitz
- Small Molecule Drug Discovery, Bristol Myers Squibb, Research & Early Development, 250 Water Street, Cambridge, MA 02141, USA
| | - Jack L Sloane
- Small Molecule Drug Discovery, Bristol Myers Squibb, Research & Early Development, 250 Water Street, Cambridge, MA 02141, USA
| | - Kevin W Gillman
- Small Molecule Drug Discovery, Bristol Myers Squibb, Research & Early Development, 250 Water Street, Cambridge, MA 02141, USA
| | - Daniel Ridge
- Small Molecule Drug Discovery, Bristol Myers Squibb, Research & Early Development, 250 Water Street, Cambridge, MA 02141, USA
| | - Michael D Mandler
- Small Molecule Drug Discovery, Bristol Myers Squibb Research & Early Development, Route 206 & Province Line Road, Princeton, NJ 08543, USA
| | | | | | - Benxiang Zhang
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | | | | | - Pablo Martín-Gago
- Research and Early Development, LEO Pharma A/S, 2750, Ballerup, Denmark
| | - Pavel Mykhailiuk
- Enamine Ltd., Winston Churchill Street 78, 02094, Kyiv, Ukraine
- Chemistry Department, Taras Shevchenko National University of Kyiv, Volodymyrska 64, 01601, Kyiv, Ukraine
| | - Keary M Engle
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Phil S Baran
- Department of Chemistry, Scripps Research, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| |
Collapse
|
2
|
Design, synthesis, and biological evaluation of quinolinedione-linked sulfonylpiperazine derivatives as NQO1-directed antitumor agents. Bioorg Chem 2023; 132:106385. [PMID: 36696730 DOI: 10.1016/j.bioorg.2023.106385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2022] [Revised: 01/14/2023] [Accepted: 01/17/2023] [Indexed: 01/22/2023]
Abstract
In the current study, a series of novel quinolinedione-linked sulfonylpiperazine derivatives have been reported as NQO1-directed antitumor agents. A majority of compounds in this study were found to be more effective in resisting the proliferation of cancer cells than that of the positive control 5-Fu and TSA. Among the tested compounds, the derivative 22r exhibited considerable effect (IC50, 3.29-5.19 µM) against the proliferation of three NQO1-rich cancer cells (HepG2, MCF-7, and A549), and was recognized to be an excellent NQO1 substrate as revealed by in vitro enzyme reduction assay and molecular docking study with NQO1. In studies on the mechanisms involved, 22r induced reactive oxygen species (ROS) production, caused DNA damage, and induced apoptosis in HepG2 cells. Remarkably, compound 22r exhibited excellent anticancer activity against HepG2 xenograft models in vivo. The study demonstrated that compound 22r provided a promising strategy for the management of malignant tumors.
Collapse
|
3
|
Reetu R, Gujjarappa R, Malakar CC. Recent Advances in Synthesis and Medicinal Evaluation of 1,2‐Benzothiazine Analogues. ASIAN J ORG CHEM 2022. [DOI: 10.1002/ajoc.202200163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Reetu Reetu
- National Institute of Technology Manipur Chemistry INDIA
| | | | - Chandi C Malakar
- National Institute of Technology Manipur Department of Chemistry Langol, Imphal 795004 Imphal INDIA
| |
Collapse
|
4
|
Wang K, Zhu H, Zhao H, Zhang K, Tian Y. Application of carbamyl in structural optimization. Bioorg Chem 2020; 98:103757. [PMID: 32217370 DOI: 10.1016/j.bioorg.2020.103757] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2019] [Revised: 02/07/2020] [Accepted: 03/12/2020] [Indexed: 12/11/2022]
Abstract
Carbamyl is considered a privileged structure in medicinal chemistry. It has a wide range of biological activities such as antimicrobial, anticancer, anti-epilepsy, for which the best evidence is a number of marketed carbamyl-containing drugs. Carbamyl is formed of primary amine and carbonyl moieties that act as hydrogen bond donors and hydrogen acceptors with residues of targets respectively, which are benefit for improving pharmacological activities. In other cases, the introduced carbamyl improves drug-like properties including oral bioavailability. In this review, we introduce the carbamyl-containing drugs and the application of carbamyl in structural optimization as a result of enhancing activities or/and drug-like properties.
Collapse
Affiliation(s)
- Kuanglei Wang
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, PR China; International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, PR China; School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, PR China
| | - Hongxi Zhu
- School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, PR China
| | - Hongqian Zhao
- School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, PR China
| | - Kun Zhang
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, PR China; International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, PR China; School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou 510006, PR China.
| | - Yongshou Tian
- School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, PR China.
| |
Collapse
|
5
|
Wang H, Liu CF, Song Z, Yuan M, Ho YA, Gutierrez O, Koh MJ. Engaging α-Fluorocarboxylic Acids Directly in Decarboxylative C–C Bond Formation. ACS Catal 2020. [DOI: 10.1021/acscatal.0c00789] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Hongyu Wang
- Department of Chemistry, National University of Singapore, 12 Science Drive 2, Republic of Singapore, 117549
| | - Chen-Fei Liu
- Department of Chemistry, National University of Singapore, 12 Science Drive 2, Republic of Singapore, 117549
| | - Zhihui Song
- Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States
| | - Mingbin Yuan
- Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States
| | - Yee Ann Ho
- Department of Chemistry, National University of Singapore, 12 Science Drive 2, Republic of Singapore, 117549
| | - Osvaldo Gutierrez
- Department of Chemistry and Biochemistry, University of Maryland, College Park, Maryland 20742, United States
| | - Ming Joo Koh
- Department of Chemistry, National University of Singapore, 12 Science Drive 2, Republic of Singapore, 117549
| |
Collapse
|
6
|
Demchuk OP, Hryshchuk OV, Vashchenko BV, Radchenko DS, Kovtunenko VO, Komarov IV, Grygorenko OO. Robust and Scalable Approach to 1,3-Disubstituted Pyridylcyclobutanes. European J Org Chem 2019. [DOI: 10.1002/ejoc.201901001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Affiliation(s)
- Oleksandr P. Demchuk
- Enamine Ltd.; Chervonotkatska Street 78 02094 Kyiv Ukraine
- Taras Shevchenko National University of Kyiv; Volodymyrska Street 60 01601 Kyiv Ukraine
| | - Oleksandr V. Hryshchuk
- Enamine Ltd.; Chervonotkatska Street 78 02094 Kyiv Ukraine
- Taras Shevchenko National University of Kyiv; Volodymyrska Street 60 01601 Kyiv Ukraine
| | - Bohdan V. Vashchenko
- Enamine Ltd.; Chervonotkatska Street 78 02094 Kyiv Ukraine
- Taras Shevchenko National University of Kyiv; Volodymyrska Street 60 01601 Kyiv Ukraine
| | - Dmytro S. Radchenko
- Enamine Ltd.; Chervonotkatska Street 78 02094 Kyiv Ukraine
- Taras Shevchenko National University of Kyiv; Volodymyrska Street 60 01601 Kyiv Ukraine
| | | | - Igor V. Komarov
- Enamine Ltd.; Chervonotkatska Street 78 02094 Kyiv Ukraine
- Taras Shevchenko National University of Kyiv; Volodymyrska Street 60 01601 Kyiv Ukraine
| | - Oleksandr O. Grygorenko
- Enamine Ltd.; Chervonotkatska Street 78 02094 Kyiv Ukraine
- Taras Shevchenko National University of Kyiv; Volodymyrska Street 60 01601 Kyiv Ukraine
| |
Collapse
|
7
|
Merchant RR, Edwards JT, Qin T, Kruszyk MM, Bi C, Che G, Bao DH, Qiao W, Sun L, Collins MR, Fadeyi OO, Gallego GM, Mousseau JJ, Nuhant P, Baran PS. Modular radical cross-coupling with sulfones enables access to sp 3-rich (fluoro)alkylated scaffolds. Science 2018; 360:75-80. [PMID: 29456201 DOI: 10.1126/science.aar7335] [Citation(s) in RCA: 149] [Impact Index Per Article: 24.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2017] [Accepted: 02/08/2018] [Indexed: 12/20/2022]
Abstract
Cross-coupling chemistry is widely applied to carbon-carbon bond formation in the synthesis of medicines, agrochemicals, and other functional materials. Recently, single-electron-induced variants of this reaction class have proven particularly useful in the formation of C(sp2)-C(sp3) linkages, although certain compound classes have remained a challenge. Here, we report the use of sulfones to activate the alkyl coupling partner in nickel-catalyzed radical cross-coupling with aryl zinc reagents. This method's tolerance of fluoroalkyl substituents proved particularly advantageous for the streamlined preparation of pharmaceutically oriented fluorinated scaffolds that previously required multiple steps, toxic reagents, and nonmodular retrosynthetic blueprints. Five specific sulfone reagents facilitate the rapid assembly of a vast set of compounds, many of which contain challenging fluorination patterns.
Collapse
Affiliation(s)
- Rohan R Merchant
- Department of Chemistry, The Scripps Research Institute (TSRI), 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Jacob T Edwards
- Department of Chemistry, The Scripps Research Institute (TSRI), 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Tian Qin
- Department of Chemistry, The Scripps Research Institute (TSRI), 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Monika M Kruszyk
- Department of Chemistry, The Scripps Research Institute (TSRI), 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Cheng Bi
- Department of Chemistry, The Scripps Research Institute (TSRI), 10550 North Torrey Pines Road, La Jolla, CA 92037, USA
| | - Guanda Che
- Asymchem Life Science (Tianjin), Tianjin Economic-Technological Development Zone, Tianjin 300457, China
| | - Deng-Hui Bao
- Asymchem Life Science (Tianjin), Tianjin Economic-Technological Development Zone, Tianjin 300457, China
| | - Wenhua Qiao
- Asymchem Life Science (Tianjin), Tianjin Economic-Technological Development Zone, Tianjin 300457, China
| | - Lijie Sun
- Asymchem Life Science (Tianjin), Tianjin Economic-Technological Development Zone, Tianjin 300457, China
| | - Michael R Collins
- Department of Chemistry, La Jolla Laboratories, Pfizer, 10770 Science Center Drive, San Diego, CA 92121, USA
| | | | - Gary M Gallego
- Department of Chemistry, La Jolla Laboratories, Pfizer, 10770 Science Center Drive, San Diego, CA 92121, USA
| | - James J Mousseau
- Pfizer Medicinal Sciences, Eastern Point Road, Groton, CT 06340, USA
| | - Philippe Nuhant
- Pfizer Medicinal Sciences, Eastern Point Road, Groton, CT 06340, USA
| | - Phil S Baran
- Department of Chemistry, The Scripps Research Institute (TSRI), 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
| |
Collapse
|
8
|
Sun D, Ye Q, Yan X, Rew Y, Fan P, He X, Jiang M, McMinn DL, Monshouwer M, Tu H, Powers JP. Synthesis, in Vitro Covalent Binding Evaluation, and Metabolism of (14)C-Labeled Inhibitors of 11β-HSD1. ACS Med Chem Lett 2014; 5:1245-50. [PMID: 25408839 DOI: 10.1021/ml500331y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2014] [Accepted: 09/23/2014] [Indexed: 01/22/2023] Open
Abstract
In this letter, we reported the design and synthesis of three potent, selective, and orally bioavailable 11β-HSD1 inhibitors labeled with (14)C: AMG 456 (1), AM-6949 (2), and AM-7715 (3). We evaluated the covalent protein binding of the labeled inhibitors in human liver microsomes in vitro and assessed their potential bioactivation risk in humans. We then studied the in vitro mechanism of 2 in human hepatocytes and the formation of reactive intermediates. Our study results suggest that 1 and 3 have low potential for metabolic bioactivation in humans, while 2 has relatively high risk.
Collapse
Affiliation(s)
- Daqing Sun
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| | - Qiuping Ye
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| | - Xuelei Yan
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| | - Yosup Rew
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| | - Peter Fan
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| | - Xiao He
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| | - Min Jiang
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| | - Dustin L. McMinn
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| | - Mario Monshouwer
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| | - Hua Tu
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| | - Jay P. Powers
- Departments of Therapeutic Discovery, ‡Metabolic Disorders, and §Pharmacokinetics
and Drug Metabolism, Amgen, Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
| |
Collapse
|
9
|
Design, synthesis and pharmacological evaluation of novel polycyclic heteroarene ethers as PDE10A inhibitors: Part I. Bioorg Med Chem Lett 2014; 24:2073-8. [DOI: 10.1016/j.bmcl.2014.03.054] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2013] [Revised: 03/06/2014] [Accepted: 03/18/2014] [Indexed: 01/26/2023]
|
10
|
Scott JS, Goldberg FW, Turnbull AV. Medicinal Chemistry of Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1). J Med Chem 2013; 57:4466-86. [DOI: 10.1021/jm4014746] [Citation(s) in RCA: 67] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- James S. Scott
- AstraZeneca Innovative Medicines, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, U.K
| | - Frederick W. Goldberg
- AstraZeneca Innovative Medicines, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, U.K
| | - Andrew V. Turnbull
- AstraZeneca Innovative Medicines, Mereside, Alderley Park, Macclesfield, Cheshire, SK10 4TG, U.K
| |
Collapse
|
11
|
Discovery and optimization of benzenesulfonanilide derivatives as a novel class of 11β-HSD1 inhibitors. Bioorg Med Chem Lett 2012; 22:3786-90. [DOI: 10.1016/j.bmcl.2012.04.005] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2012] [Revised: 03/29/2012] [Accepted: 04/02/2012] [Indexed: 11/16/2022]
|
12
|
Penning TM. Human hydroxysteroid dehydrogenases and pre-receptor regulation: insights into inhibitor design and evaluation. J Steroid Biochem Mol Biol 2011; 125:46-56. [PMID: 21272640 PMCID: PMC3104102 DOI: 10.1016/j.jsbmb.2011.01.009] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/20/2010] [Revised: 01/18/2011] [Accepted: 01/18/2011] [Indexed: 11/16/2022]
Abstract
Hydroxysteroid dehydrogenases (HSDs) represent a major class of NAD(P)(H) dependent steroid hormone oxidoreductases involved in the pre-receptor regulation of hormone action. This is achieved by HSDs working in pairs so that they can interconvert ketosteroids with hydroxysteroids resulting in a change in ligand potency for nuclear receptors. HSDs belong to two protein superfamilies the aldo-keto reductases and the short-chain dehydrogenase/reductases. In humans, many of the important enzymes have been thoroughly characterized including the elucidation of their three-dimensional structures. Because these enzymes play fundamental roles in steroid hormone action they can be considered to be drug targets for a variety of steroid driven diseases, e.g. metabolic syndrome and obesity, inflammation, and hormone dependent malignancies of the endometrium, prostate and breast. This article will review how fundamental knowledge of these enzymes can be exploited in the development of isoform specific HSD inhibitors from both protein superfamilies. Article from the Special issue on Targeted Inhibitors.
Collapse
Affiliation(s)
- Trevor M Penning
- Center of Excellence in Environmental Toxicology, Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6084, USA.
| |
Collapse
|
13
|
Kim SH, Kwon SW, Chu SY, Lee JH, Narsaiah B, Kim CH, Kang SK, Kang NS, Rhee SD, Bae MA, Ahn SH, Ha DC, Kim KY, Ahn JH. Identification of Cyclicsulfonamide Derivatives with an Acetamide Group as 11.BETA.-Hydroxysteroid Dehydrogenase 1 Inhibitors. Chem Pharm Bull (Tokyo) 2011; 59:46-52. [DOI: 10.1248/cpb.59.46] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
| | | | - So Young Chu
- Drug Discovery Division, Korea Research Institute of Chemical Technology
| | | | - Banda Narsaiah
- Drug Discovery Division, Korea Research Institute of Chemical Technology
| | - Chi Hyun Kim
- Drug Discovery Division, Korea Research Institute of Chemical Technology
| | - Seung Kyu Kang
- Drug Discovery Division, Korea Research Institute of Chemical Technology
| | - Nam Sook Kang
- Drug Discovery Division, Korea Research Institute of Chemical Technology
| | - Sang Dal Rhee
- Drug Discovery Division, Korea Research Institute of Chemical Technology
| | - Myung Ae Bae
- Drug Discovery Division, Korea Research Institute of Chemical Technology
| | - Sung Hoon Ahn
- Drug Discovery Division, Korea Research Institute of Chemical Technology
| | | | - Ki Young Kim
- Drug Discovery Division, Korea Research Institute of Chemical Technology
| | - Jin Hee Ahn
- Drug Discovery Division, Korea Research Institute of Chemical Technology
| |
Collapse
|
14
|
Sun D, Wang Z, Caille S, DeGraffenreid M, Gonzalez-Lopez de Turiso F, Hungate R, Jaen JC, Jiang B, Julian LD, Kelly R, McMinn DL, Kaizerman J, Rew Y, Sudom A, Tu H, Ursu S, Walker N, Willcockson M, Yan X, Ye Q, Powers JP. Synthesis and optimization of novel 4,4-disubstituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors. Bioorg Med Chem Lett 2010; 21:405-10. [PMID: 21093258 DOI: 10.1016/j.bmcl.2010.10.129] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2010] [Revised: 10/23/2010] [Accepted: 10/26/2010] [Indexed: 11/20/2022]
Abstract
The synthesis and SAR of a series of 4,4-disubstituted cyclohexylbenzamide inhibitors of 11β-HSD1 are described. Optimization rapidly led to potent, highly selective, and orally bioavailable inhibitors demonstrating efficacy in both rat and non-human primate ex vivo pharmacodynamic models.
Collapse
Affiliation(s)
- Daqing Sun
- Amgen Inc, 1120 Veterans Boulevard, South San Francisco, CA 94080, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Yan X, Wang Z, Sudom A, Cardozo M, DeGraffenreid M, Di Y, Fan P, He X, Jaen JC, Labelle M, Liu J, Ma J, McMinn D, Miao S, Sun D, Tang L, Tu H, Ursu S, Walker N, Ye Q, Powers JP. The synthesis and SAR of novel diarylsulfone 11β-HSD1 inhibitors. Bioorg Med Chem Lett 2010; 20:7071-5. [PMID: 20971000 DOI: 10.1016/j.bmcl.2010.09.097] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2010] [Revised: 09/15/2010] [Accepted: 09/16/2010] [Indexed: 10/19/2022]
Abstract
In this communication, human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitory activities of a novel series of diarylsulfones are described. Optimization of this series resulted in several highly potent 11β-HSD1 inhibitors with excellent pharmacokinetic (PK) properties. Compound (S)-25 showed excellent efficacy in a non-human primate ex vivo pharmacodynamic model.
Collapse
Affiliation(s)
- Xuelei Yan
- Amgen Inc., 1120 Veterans Boulevard, South San Francisco, CA 94080, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Kim SH, Ramu R, Kwon SW, Lee SH, Kim CH, Kang SK, Rhee SD, Bae MA, Ahn SH, Ha DC, Cheon HG, Kim KY, Ahn JH. Discovery of cyclicsulfonamide derivatives as 11 beta-hydroxysteroid dehydrogenase 1 inhibitors. Bioorg Med Chem Lett 2009; 20:1065-9. [PMID: 20045318 DOI: 10.1016/j.bmcl.2009.12.035] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2009] [Revised: 11/20/2009] [Accepted: 12/07/2009] [Indexed: 01/27/2023]
Abstract
A new series of cyclic sulfonamide derivatives was synthesized and evaluated for their ability to inhibit 11beta-HSD1. Cyclic sulfonamides with phenylacetyl substituents at the 2-position showed nanomolar inhibitory activities. Among them, compound 4e exhibited a good in vitro inhibitory activity and selectivity toward human 11beta-HSD2.
Collapse
Affiliation(s)
- Se Hoan Kim
- Department of Chemistry, Korea University, Seoul 121-742, Republic of Korea
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|